[[ string CodeUnique = system.Tools.GenerateGUID(); string li_email_MD5 = System.Tools.Hash.MD5.GetString(Contact.f_EMail); string li_jobid = (Mailing.idBatch is not null) ? Mailing.idBatch.ToString() : Sendlog.idSendLog.ToString(); string li_suffix = "&li=" + Project.idProject.ToString() + "&m=" + li_email_MD5 + "&p=" + CodeUnique; ]]BE Responsive Newsletter
 

If you cannot view this e-mail correctly, please [[IF(Config.isShowMessage == 0){]]click here[[}]]

 
Wednesday 29 May 2024
Benefits Canada Daily Newsletters
Go to website
Manage subscription
Top Stories
Coverage for high-cost, specialty drugs missing from rollout of feds' pharmacare plan: experts
Coverage for high-cost, specialty drugs missing from rollout of feds' pharmacare plan: experts
It would benefit more Canadians if the program added more drugs for diabetes and contraceptives, as well as drugs for other health conditions, such as high-cost drugs or drugs for rare diseases, says the Benefits Alliance’s Carolyne Eagan.
Survey finds 77% of U.S. workers think employers' motivation for returning to office is about control
Survey finds 77% of U.S. workers think employers' motivation for returning to office is about control
Two-fifths (40%) of workers said their employer wants to increase office attendance and more than a quarter (28%) reported their employer has threatened to fire workers who don’t comply, according to a new survey by MyPerfectResume.com.
Cross-border pension plans increasing due to political, economic tension: survey
Cross-border pension plans increasing due to political, economic tension: survey
The number of international pension plans and international savings plans that are offered in countries operating in challenging political or economic circumstances has risen to 126, up from 54 in 2019, according to a new survey by WTW.
 
From the Archives
National pharmacare program will cost $40BN annually with shift of $14BN in private insurance
National pharmacare program will cost $40BN annually with shift of $14BN in private insurance
In a 2023 report, the PBO estimated the cost of a single-payer universal drug plan to the public sector will be $11.2 billion in 2024/25, increasing to $13.4 billion in 2027/28.
 
In Case You Missed It
Expert panel: New research brings mortality improvement into spotlight for pension plan sponsors
Expert panel: New research brings mortality improvement into spotlight for pension plan sponsors
One of the most important assumptions actuaries make when valuing pension plan liabilities and costs is the mortality assumption because it affects how long pension plan members are assumed to live and, as a result, for how long they are expected to collect their pensions once they retire.
Employers rethinking value of employee connections in era of remote work: report
Employers rethinking value of employee connections in era of remote work: report
The two most popular responses to foster social connections among remote workers were regular check-ins and in-person social events, according to a new report by the Conference Board of Canada.